NCT05161247View on ClinicalTrials.gov

Reproductive Outcome After Sperm Selection for Intracytoplasmic Sperm Injection (ICSI) Using Zona Pellucida Proteins

NACompletedINTERVENTIONAL
Enrollment

368

Participants

Timeline

Start Date

December 3, 2021

Primary Completion Date

March 3, 2024

Study Completion Date

July 5, 2024

Conditions
Infertility, Male
Interventions
OTHER

Zona pellucida sperm selection

Sperm selection for ICSI based on the spermatozoa ability to adhere to immobilized zona pellucida proteins.

OTHER

Conventional sperm selection

Sperm selection for ICSI based on the sperm morphology.

OTHER

Intracytoplasmic Sperm Injection (ICSI)

Normal ICSI procedure.

Trial Locations (1)

1373

Nadezhda Women's Health Hospital, Sofia

All Listed Sponsors
lead

Nadezhda Women's Health Hospital

OTHER

NCT05161247 - Reproductive Outcome After Sperm Selection for Intracytoplasmic Sperm Injection (ICSI) Using Zona Pellucida Proteins | Biotech Hunter | Biotech Hunter